X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-07-16 | NKTX | Hager Alicia J. | GC | S - Sale | $8.00 | -3,396 | 103,819 | -3% | -$27,168 | ||||||
2024-06-18 | NKTX | Trager James | Chief Scientific Officer | S - Sale | $5.60 | -456 | 150,959 | 0% | -$2,554 | ||||||
2024-06-18 | NKTX | Hastings Paul J | CEO | S - Sale | $5.60 | -1,770 | 240,737 | -1% | -$9,912 | ||||||
2024-06-18 | NKTX | Shook David | Chief Medical Officer | S - Sale | $5.60 | -456 | 116,524 | 0% | -$2,554 | ||||||
2024-06-18 | NKTX | Hager Alicia J. | GC | S - Sale | $5.60 | -727 | 107,215 | -1% | -$4,071 | ||||||
2024-06-18 | NKTX | Brandenberger Ralph | Chief Technical Officer | S - Sale | $5.60 | -229 | 79,743 | 0% | -$1,282 | ||||||
| D | 2024-03-27 | NKTX | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $10.00 | +3,000,000 | 10,805,129 | +38% | +$30,000,000 | |||||
2024-03-27 | NKTX | George Simeon | Dir | P - Purchase | $10.00 | +2,000,000 | 3,333,333 | +150% | +$20,000,000 | ||||||
| D | 2024-03-01 | NKTX | Brandenberger Ralph | Chief Technical Officer | S - Sale+OE | $12.51 | -8,367 | 79,972 | -9% | -$104,671 | |||||
2024-02-12 | NKTX | Trager James | Chief Scientific Officer | S - Sale | $12.00 | -4,143 | 149,415 | -3% | -$49,716 | ||||||
2024-01-16 | NKTX | Shook David | Chief Medical Officer | S - Sale | $8.74 | -3,552 | 114,980 | -3% | -$31,044 | ||||||
2024-01-16 | NKTX | Trager James | Chief Scientific Officer | S - Sale | $8.74 | -4,560 | 153,558 | -3% | -$39,854 | ||||||
2024-01-16 | NKTX | Brandenberger Ralph | Chief Technical Officer | S - Sale | $8.74 | -2,512 | 81,576 | -3% | -$21,955 | ||||||
2024-01-16 | NKTX | Hastings Paul J | CEO | S - Sale | $8.74 | -9,697 | 390,507 | -2% | -$84,752 | ||||||
2024-01-16 | NKTX | Hager Alicia J. | GC | S - Sale | $8.74 | -4,554 | 107,942 | -4% | -$39,802 | ||||||
2023-08-21 | NKTX | Shook David | Chief Medical Officer | S - Sale | $1.83 | -1,331 | 60,532 | -2% | -$2,436 | ||||||
2023-06-20 | NKTX | Trager James | Chief Scientific Officer | S - Sale | $4.85 | -439 | 100,118 | 0% | -$2,129 | ||||||
2023-06-20 | NKTX | Brandenberger Ralph | Chief Technical Officer | S - Sale | $4.85 | -221 | 28,088 | -1% | -$1,072 | ||||||
2023-06-20 | NKTX | Hager Alicia J. | GC | S - Sale | $4.85 | -701 | 56,496 | -1% | -$3,400 | ||||||
2023-06-20 | NKTX | Shook David | Chief Medical Officer | S - Sale | $4.85 | -439 | 61,863 | -1% | -$2,129 | ||||||
2023-06-20 | NKTX | Mahmood Nadir | See Remarks | S - Sale | $4.85 | -526 | 85,776 | -1% | -$2,551 | ||||||
2023-06-20 | NKTX | Hastings Paul J | CEO | S - Sale | $4.85 | -1,704 | 313,402 | -1% | -$8,264 | ||||||
| D | 2023-01-17 | NKTX | Trager James | Chief Scientific Officer | S - Sale+OE | $5.49 | -1,115 | 98,557 | -1% | -$6,121 | |||||
| D | 2023-01-17 | NKTX | Shook David | Chief Medical Officer | S - Sale+OE | $5.49 | -175 | 60,302 | 0% | -$961 | |||||
| D | 2023-01-17 | NKTX | Mahmood Nadir | See Remarks | S - Sale+OE | $5.49 | -1,122 | 84,302 | -1% | -$6,160 | |||||
| D | 2023-01-17 | NKTX | Hastings Paul J | CEO | S - Sale+OE | $5.49 | -3,691 | 313,106 | -1% | -$20,264 | |||||
| D | 2023-01-17 | NKTX | Hager Alicia J. | GC | S - Sale+OE | $5.49 | -1,103 | 57,197 | -2% | -$6,055 | |||||
| D | 2023-01-17 | NKTX | Brandenberger Ralph | Chief Technical Officer | S - Sale+OE | $5.49 | -491 | 28,309 | -2% | -$2,696 | |||||
| D | 2022-10-06 | NKTX | Brandenberger Ralph | Chief Technical Officer | S - Sale+OE | $14.02 | -842 | 7,800 | -10% | -$11,805 | |||||
| M | 2022-09-28 | NKTX | Hastings Paul J | CEO | S - Sale | $13.03 | -23,874 | 250,461 | -9% | -$311,089 | |||||
2022-09-21 | NKTX | Hastings Paul J | CEO | S - Sale | $13.01 | -6,126 | 274,335 | -2% | -$79,717 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |